Phase I trial of ixabepilone administered as three oral doses each separated by 6 hours every 3 weeks in patients with advanced solid tumors | Zendy

AI Assistant Blog Pricing

Phase I trial of ixabepilone administered as three oral doses each separated by 6 hours every 3 weeks in patients with advanced solid tumors

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.